OrthoPediatrics Corp. (KIDS)
USD 23.62
(-10.22%)
USD 23.62
(-10.22%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 137.01 Million USD | 6.39% |
| 2022 | 112.45 Million USD | 23.2% |
| 2021 | 91.27 Million USD | 20.99% |
| 2020 | 75.44 Million USD | 18.44% |
| 2019 | 63.69 Million USD | 21.95% |
| 2018 | 52.23 Million USD | 27.64% |
| 2017 | 40.92 Million USD | 25.94% |
| 2016 | 32.49 Million USD | 15.11% |
| 2015 | 28.22 Million USD | 18.89% |
| 2014 | 23.74 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 41.68 Million USD | 13.07% |
| 2024 Q1 | 36.86 Million USD | 25.83% |
| 2023 Q3 | 34.47 Million USD | -3.19% |
| 2023 FY | 119.63 Million USD | 6.39% |
| 2023 Q1 | 32.15 Million USD | 8.87% |
| 2023 Q2 | 35.61 Million USD | 10.76% |
| 2023 Q4 | 29.3 Million USD | -15.01% |
| 2022 FY | 112.45 Million USD | 23.2% |
| 2022 Q4 | 29.53 Million USD | 1.0% |
| 2022 Q3 | 29.24 Million USD | 1.8% |
| 2022 Q2 | 28.72 Million USD | 15.12% |
| 2022 Q1 | 24.95 Million USD | 5.54% |
| 2021 FY | 91.27 Million USD | 20.99% |
| 2021 Q2 | 23.28 Million USD | 4.44% |
| 2021 Q3 | 22.19 Million USD | -4.68% |
| 2021 Q1 | 22.29 Million USD | 3.62% |
| 2021 Q4 | 23.64 Million USD | 6.51% |
| 2020 Q2 | 17.07 Million USD | 2.2% |
| 2020 Q3 | 20.13 Million USD | 17.91% |
| 2020 Q4 | 21.51 Million USD | 6.86% |
| 2020 Q1 | 16.71 Million USD | -4.41% |
| 2020 FY | 75.44 Million USD | 18.44% |
| 2019 Q2 | 15.4 Million USD | 15.23% |
| 2019 FY | 63.69 Million USD | 21.95% |
| 2019 Q4 | 17.48 Million USD | 0.27% |
| 2019 Q3 | 17.43 Million USD | 13.14% |
| 2019 Q1 | 13.37 Million USD | 8.01% |
| 2018 FY | 52.23 Million USD | 27.64% |
| 2018 Q1 | 13.31 Million USD | 2.13% |
| 2018 Q2 | 13.39 Million USD | 0.57% |
| 2018 Q3 | 13.14 Million USD | -1.8% |
| 2018 Q4 | 12.38 Million USD | -5.85% |
| 2017 Q3 | 10.24 Million USD | 9.14% |
| 2017 Q1 | 8.25 Million USD | -14.5% |
| 2017 Q4 | 13.03 Million USD | 27.22% |
| 2017 FY | 40.92 Million USD | 25.94% |
| 2017 Q2 | 9.38 Million USD | 13.78% |
| 2016 Q4 | 9.65 Million USD | 25.68% |
| 2016 FY | 32.49 Million USD | 15.11% |
| 2016 Q3 | 7.68 Million USD | -0.14% |
| 2016 Q2 | 7.69 Million USD | 2.96% |
| 2016 Q1 | 7.47 Million USD | 0.0% |
| 2015 FY | 28.22 Million USD | 18.89% |
| 2015 Q1 | 6.25 Million USD | 0.0% |
| 2014 FY | 23.74 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -1120.768% |
| Cerus Corporation | 143.15 Million USD | 4.286% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -1106.061% |
| Talis Biomedical Corporation | 67.18 Million USD | -103.94% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -449.262% |
| Inogen, Inc. | 236.08 Million USD | 41.962% |
| Spectral AI, Inc. | 20.86 Million USD | -556.725% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -144.69% |
| CVRx, Inc. | 76.14 Million USD | -79.952% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -3783.763% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -997.117% |
| Orthofix Medical Inc. | 667.42 Million USD | 79.471% |
| Venus Concept Inc. | 80.47 Million USD | -70.261% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -142.177% |
| Bioventus Inc. | 409.91 Million USD | 66.574% |
| BrainsWay Ltd. | 28.01 Million USD | -389.039% |
| Envoy Medical, Inc. | 17.89 Million USD | -665.555% |
| electroCore, Inc. | 32.03 Million USD | -327.77% |
| IceCure Medical Ltd | 16.87 Million USD | -711.916% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -222.914% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -677.059% |
| MaxCyte, Inc. | 84.84 Million USD | -61.493% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -1003.944% |
| Nexalin Technology, Inc. | 5.78 Million USD | -2270.015% |
| PAVmed Inc | 64.82 Million USD | -111.361% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -168.254% |
| RxSight, Inc. | 103.85 Million USD | -31.939% |
| Sight Sciences, Inc. | 126.44 Million USD | -8.359% |
| SI-BONE, Inc. | 156.35 Million USD | 12.364% |
| TELA Bio, Inc. | 84.18 Million USD | -62.756% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -95.585% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 32.624% |
| LivaNova PLC | 843.54 Million USD | 83.757% |
| 908 Devices Inc. | 68.08 Million USD | -101.262% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 71.667% |
| Nemaura Medical Inc. | 7.13 Million USD | -1819.355% |
| NeuroPace, Inc. | 75.29 Million USD | -81.974% |
| LENSAR, Inc. | 33.33 Million USD | -311.024% |
| Apyx Medical Corporation | 51.01 Million USD | -168.57% |
| Cutera, Inc. | 197.72 Million USD | 30.702% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -452.92% |
| BioSig Technologies, Inc. | 28.53 Million USD | -380.263% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 28.44% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -279.975% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 83.618% |
| Axonics, Inc. | 270.2 Million USD | 49.29% |
| Outset Medical, Inc. | 198.77 Million USD | 31.067% |
| IRIDEX Corporation | 31.81 Million USD | -330.688% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 23.971% |
| IRadimed Corporation | 30.12 Million USD | -354.868% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -1505.942% |
| INVO Bioscience, Inc. | 7.85 Million USD | -1644.733% |
| Telesis Bio, Inc. | 63.48 Million USD | -115.815% |
| Viemed Healthcare, Inc. | 98.45 Million USD | -39.172% |
| Varex Imaging Corporation | 224.8 Million USD | 39.048% |
| Quipt Home Medical Corp. | 148.66 Million USD | 7.835% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1068.805% |
| Pulmonx Corporation | 112.68 Million USD | -21.593% |
| Dynatronics Corporation | 9.9 Million USD | -1282.909% |
| Modular Medical, Inc. | 17.52 Million USD | -681.67% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -578.749% |
| Semler Scientific, Inc. | 38.94 Million USD | -251.836% |
| InMode Ltd. | 215.68 Million USD | 36.471% |
| Bruker Corporation | 1.07 Billion USD | 87.271% |
| Cytosorbents Corporation | 48.33 Million USD | -183.467% |
| DexCom, Inc. | 1.69 Billion USD | 91.898% |
| Align Technology, Inc. | 2.07 Billion USD | 93.402% |
| Viveve Medical, Inc. | 22.17 Million USD | -517.954% |
| ZimVie Inc. | 275.12 Million USD | 50.198% |
| Movano Inc. | 29.69 Million USD | -361.499% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 0.184% |
| Nexalin Technology, Inc. | 5.78 Million USD | -2270.015% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -3783.763% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 77.198% |
| Profound Medical Corp. | 33.6 Million USD | -307.756% |
| Insulet Corporation | 939.9 Million USD | 85.422% |
| enVVeno Medical Corporation | 25.23 Million USD | -442.908% |
| Surmodics, Inc. | 98.69 Million USD | -38.828% |
| iCAD, Inc. | 22.22 Million USD | -516.508% |
| Nuwellis, Inc. | 22.61 Million USD | -505.93% |
| Biotricity, Inc. | 17.18 Million USD | -697.338% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 69.271% |
| Aethlon Medical, Inc. | 12.27 Million USD | -1016.016% |
| InspireMD, Inc. | 22.95 Million USD | -497.033% |
| PAVmed Inc. | 64.82 Million USD | -111.361% |
| BIOLASE, Inc. | 34.66 Million USD | -295.312% |
| Beyond Air, Inc. | 61.7 Million USD | -122.073% |
| FONAR Corporation | 28.6 Million USD | -379.009% |
| AxoGen, Inc. | 149.33 Million USD | 8.248% |
| Vivani Medical, Inc. | 26.96 Million USD | -408.136% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 22.628% |
| Inari Medical, Inc. | 448.59 Million USD | 69.456% |
| UFP Technologies, Inc. | 58.08 Million USD | -135.878% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -2680.644% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -2068.609% |
| Tenon Medical, Inc. | 16.96 Million USD | -707.514% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -1753.361% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -210.681% |
| AdaptHealth Corp. | 1.07 Billion USD | 87.289% |
| Sintx Technologies, Inc. | 15.2 Million USD | -801.381% |
| NanoVibronix, Inc. | 4.97 Million USD | -2655.258% |
| Quanterix Corporation | 118.1 Million USD | -16.019% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1068.805% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -848.754% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 65.105% |
| TransMedics Group, Inc. | 182.82 Million USD | 25.053% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -388.22% |
| NeuroMetrix, Inc. | 11.09 Million USD | -1134.524% |
| Hyperfine, Inc. | 52.87 Million USD | -159.152% |
| Establishment Labs Holdings Inc. | 172 Million USD | 20.339% |
| Biomerica, Inc. | 6.97 Million USD | -1863.586% |
| Bone Biologics Corporation | 9.42 Million USD | -1353.273% |
| AVITA Medical, Inc. | 80.77 Million USD | -69.622% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -1228.835% |
| Silk Road Medical, Inc | 186.35 Million USD | 26.475% |